USE OF MAPK INHIBITORS TO REDUCE LOSS OF HEMATOPOIETIC STEM CELLS DURING EX VIVO CULTURE AND/OR GENETIC MANIPULATION

• 收藏
• 分享

专利权人:

Children's Hospital Medical Center

发明人:

Malik Punam,Filippi Marie-Dominique

申请号：

US201615771683

公开号：

US2018325947(A1)

申请日:

2016.10.27

申请国别(地区):

美国

年份:

2018

代理人:

摘要：

Provided herein are methods for preparing hematopoietic stem cells (HSCs), for example, human HSCs suitable for engraftment in the presence of a p38 MAPK inhibitor. Methods for assessing engraftment of HSCs (e.g., human HSCs) are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/